Teprotumumab significantly improved proptosis versus placebo in longstanding/low inflammation thyroid eye disease (TED) according to data from the first placebo-controlled trial of the drug that was recently published in The Journal of Clinical Endocrinology & Metabolism. (Horizon Therapeutics funded the trial and is marketing the drug as TEPEZZA.) Researchers led by Raymond S. Douglas, MD,...
As we start the year, we are devoting the lion’s share of the editorial pages this month to thyroid cancer. From its diagnosis and treatment to detailed studies about hypoparathyroidism, risk stratification for thyroid nodules, and more. With thyroid cancer being the most common endocrine cancer in the world, we thought it would be appropriate...Women Exposed to Toxic Metals May Experience Earlier Aging of Their Ovaries
Middle-aged women who are exposed to toxic metals may have fewer eggs in their ovaries as they approach menopause, according to new research published in The Journal of Clinical Endocrinology & Metabolism. Diminished ovarian reserve is when women have fewer eggs compared to others their age. The condition may be linked to health problems such as...
Getting Back to Normal: Options for Treating Hypoparathyroidism
Endocrine News talks to Aliya Khan, MD, about the debilitating effects of hypoparathyroidism, new treatment guidelines she helped create, and exciting news from trials that showed promising results that could allow these patients to have a much-improved quality of life, both physical and psychological. “I wish I had this medicine when I was a kid,”...
For Your Information: Recent Revelations on Thyroid Cancer Treatment
Thyroid cancer is the most common endocrine cancer in the world with over 62,000 newly diagnosed cases each year in the U.S. alone. Here, we look at some of the latest research that includes a study from Endocrine Reviews on radiation-induced thyroid cancer; a JCEM Case Reports paper on false positive results in metastatic thyroid...
Beuschlein Named Editor-in-Chief of European Journal of Endocrinology
Endocrine Society member and 2024 recipient of the Transatlantic Alliance Award, Felix Beuschlein, MD, has been named editor-in-chief of the European Society of Endocrinology (ESE)’s flagship journal, the European Journal of Endocrinology (EJE). He will assume his post in May 2024 when the current editor-in-chief and fellow Endocrine Society member, Wiebke Arlt, MD, DSc, FRCP,...
The start of a new year offers an ideal time to reflect on our career goals and what we need to do to achieve them. As your professional home, the Endocrine Society offers a myriad of opportunities to help build your CV and advance your career. This is an ideal time to register for our...Standardized Testing: Universal Risk Stratification System Needed for Thyroid Nodules
With thyroid cancer patients often getting different — and sometimes conflicting — treatment recommendations from a variety of diagnostic tools, Priyanka Majety, MD, talks to Endocrine News about why it’s time for clinicians to coalesce around a single set of standards for these cases, which could potentially eliminate unnecessary procedures. Priyanka Majety, MD, assistant professor...
